GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Gelstat Patents
5
Total DocumentsApplications and Grants
000
Total PatentsFamilies
000
Granted
000
Pending
000
Expiringin next 12 mo
Gelstat Recent Patent Activity
Publication ID
Patent Title
Status
First Filing Date
Technology (CPC)
Citations
AU-2003284322-A1
Dietary supplement comprising parthenolide
Abandoned
05-Nov-2002
000000000
EP-1558270-A1
Dietary supplement comprising parthenolide
Withdrawn
05-Nov-2002
000000000
US-20040086579-A1
Orally administering the oral dosage comprising parthenolide; retaining at least a portion of the administered oral dosage in the oral cavity for a time sufficient to allow absorption of parthenolide by oral mucosal tissues
Abandoned
05-Nov-2002
000000000
CA-2503644-A1
Dietary supplement comprising parthenolide
Abandoned
05-Nov-2002
000000000
US-20060013904-A1
Treatment method comprising administering feverfew to oral mucosal tissues in solid or semi-solid form